Definitive Contract 75A50122C00074

Award Date 9/30/22
Potential Completion Date 9/30/27
Potential Value $39M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $14.8 million firm fixed price purchase order to Hologic, Inc. to deliver its respiratory panel test for SARS-CoV, influenza A, influenza B, and RSV. The test will be used on Hologic's Panther Fusion system. The contract supports the agency's coronavirus COVID-19 response efforts and requires performance in San Diego, California over a base period ending in September 2022. No set...
This $699,000 firm fixed price contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Hologic, Inc. to develop a molecular diagnostic test to detect SARS-CoV-2 using the Hologic Panther Fusion system. The test will be developed under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed therapeutic candidates to aid long-term outcomes from lung injury. The...
This contract award to Hologic, Inc. provides $130,882.50 in funding for the company to supply SARS-CoV-2 testing kits to the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The award, issued on August 24, 2020, has a completion date of September 30, 2020 and utilizes a firm fixed price contract type. Hologic, a for-profit medical technology company, has previously supplied a range of diagnostic instruments, assays, and reagents to the...
This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
Hologic, Inc. was awarded a $10.986 million firm fixed price purchase order by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to provide APTIMA SARS-COV-2 tests on Hologic Panther systems. The tests and associated diagnostic equipment will support the federal government's response efforts to the Coronavirus COVID-19 pandemic and will be delivered to a location in San Diego, California over a one year period concluding in August...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Hologic, Inc., a medical technology company, for SARS-COV-2 assay EUA tests. The contract has a ceiling value of $688,400.00 and a completion date of March 1, 2022. The contract is not set aside for any specific business type. Hologic, Inc. is a for-profit organization and the parent company of Hologic Limited Partnership, which is the awardee. The company has an extensive portfolio of federal contract...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Hologic Sales And Service, LLC, a subsidiary of medical technology company Hologic, Inc. The contract has a ceiling value of $251,475.00 and provides for the delivery of 250 APTIMA SARS-COV-2/FLU ASSAY test kits. The contract does not have a small business set-aside designation, indicating Hologic Sales And Service, LLC competed as a full-sized business. The contract has an ultimate completion date...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Hologic, Inc. for the APTIMA SARS-COV-2 ASSAY FFP, 250-TEST, COVID TESTING SUPPLIES. The contract has a potential value of $228,450.00 and a completion date of January 11, 2022. Hologic, Inc. is a medical technology company that provides a range of diagnostic products, including reagents, test kits, and instrumentation, to federal government customers such as the Department of Veterans Affairs and the Department...
This is a federal contract award from the Defense Health Agency (DHA) to Hologic Sales And Service, LLC, a subsidiary of Hologic, Inc., for the provision of SARS-COV-2 assay kits. The contract has a ceiling value of $4,743,800.00 and a period of performance running through September 30, 2028. The contract is a firm-fixed-price purchase order with no set-aside designation, indicating Hologic Sales And Service, LLC competes as a full-sized business. Hologic, Inc. is the parent company of the prime...

This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027.

This contract was awarded under a Broad Agency Announcement (BAA) originally issued by BARDA in 2017 to solicit proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats. The BAA sought proposals focused on areas including vaccines, therapeutics, diagnostics, and other technologies to support BARDA's public health emergency preparedness mission. There was no set-aside designation for this opportunity.

Generated 2/13/25, 9:35 AM